A Retrospective Cohort Study to Characterize Propionic Acidemia Patients

ModernaTX, Inc.46 个研究点分布在 9 个国家目标入组 60 人2023年6月16日

概览

阶段: 不适用
干预措施: PA Participants
疾病 / 适应症: 未指定
发起方: ModernaTX, Inc.
入组人数: 60
试验地点: 46
主要终点: Number of Annualized Clinical Event Committee (CEC)-adjudicated Metabolic Decompensation Events (MDEs)
状态: 招募中
最后更新: 2个月前

概览研究者入排标准研究组 & 干预措施结局指标研究点相似试验

概览

简要总结

This is a non-interventional, observational, global, multicenter, study describing participant characteristics, clinical outcomes, and event rates in participants with propionic acidemia (PA).

详细描述

Data will be abstracted through medical record review ensuring inclusion only of data from participants meeting all the inclusion criteria and none of the censoring criteria. Data will be collected retrospectively from study sites, including medical clinics, hospitals and academic medical centers.

注册库

clinicaltrials.gov

开始日期

2023年6月16日

结束日期

2026年9月30日

最后更新

2个月前

研究类型

Observational

性别

All

研究者

发起方

ModernaTX, Inc.

责任方

Sponsor

入排标准

入选标准

•Participants' medical records are eligible for abstraction only if all of the following criteria apply:
•Confirmed diagnosis of PA based on diagnosis by molecular genetic testing (propionyl-CoA carboxylase subunitα\[PCCA\] and/or propionyl-CoA carboxylase subunitβ\[PCCB\] mutations).
•Participant provided informed consent (and assent, as applicable).
•Medical records with sufficient data to support medical encounter for CEC adjudication (MEA adjudication) must be available dating back to birth or 01 January 2015, whichever occurs later. Participants born prior to 2015 will require additional information to confirm eligibility.
•Experienced at least one MDE in the 24 months preceding the Index Date or experienced at least 3 MDEs within any one 12-month retrospective review period (based on Index Date) dating back to birth or 01 January 2015, whichever occurs later.
•Must have a confirmed age (months) of disease onset (early or late, where early is defined as the neonatal period).
•Participants who meet any of the censoring criteria listed below may be enrolled into the study if they have a minimum of 2 years of data available for abstraction prior to meeting the censoring criteria and they meet all inclusion criteria based on the data available for abstraction.
•Censoring Criteria:
•Participants medical records meeting the following censoring criterion will not be abstracted:
•Participation in a clinical study of any investigational agent.

排除标准

•Participant's medical records will not be eligible for abstraction if the participant meets the following exclusion criteria:
•\- Participation (prior or ongoing) in clinical study mRNA-3927-P101 (NCT04159103) or mRNA-3927-P101-EXT (NCT05130437).

研究组 & 干预措施

PA Participants

Participants with PA who meet all eligibility criteria for medical record abstraction.

结局指标

主要结局

Number of Annualized Clinical Event Committee (CEC)-adjudicated Metabolic Decompensation Events (MDEs)

时间窗: Up to 10 years

次要结局

Number of CEC-adjudicated MDEs as Assessed by a Pre-Specified Severity Rating Scale(Up to 10 years)
Number of Annualized CEC-adjudicated PA-related Hospitalizations(Up to 10 years)
Number of Annualized CEC-adjudicated MDE-related Hospitalizations(Up to 10 years)
Number of Annualized CEC-adjudicated PA-related Urgent Healthcare Visits(Up to 10 years)